GC012F
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for GC012F, covering 2025-01-06 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus [Phase 1, Phase 2]